During the past decade, ProScience Research Group conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 18 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 15 clinical trials were completed. i.e. 93.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProScience Research Group" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "Sunovion" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Karuna Therapeutics" with 3 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProScience Research Group" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ProScience Research Group" are "Schizophrenia" (11 trials), "Depressive Disorder, Major" (7 trials), "Major Depressive Disorder" (4 trials), "Attention Deficit Hyperactivity Disorder" (2 trials) and "Bipolar I Disorder" (2 trials). Many other conditions were trialed in "ProScience Research Group" in a lesser frequency.

Most popular intervention types in "ProScience Research Group" are "Drug" (35 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Rapastinel" (4 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "Aticaprant" (2 trials) and "Brexpiprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "ProScience Research Group" are 36 trials for "All" genders.

Currently, there are NaN active trials in "ProScience Research Group". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in ProScience Research Group, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in ProScience Research Group, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".